Do you want to read an article? Please log in or register.
Lung Cancer Screening in a Population from Northeast Italy Exposed to Both Asbestos and Smoking: A Cost-Effectiveness Analysis
Lung Cancer
Related content
Lung Cancer
Associations between Prior Lung Diseases and Risk of Lung Cancer in Populations With No Smoking History: A Systematic Review and Meta-Analysis
Chest
Swami N, Hong JH, Kho S, Kang HM, Chun-Chia Lin L, Ni SC, Florez N, Lan Q, Rothman N, Dee EC, Gomez SL, Cheng I
doi: 10.1016/j.chest.2025.12.034
Lung Cancer
A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trials
Nat Commun
Welz M, van der Aalst CM, Alfons A, Naghi AA, Heuvelmans MA, Groen HJM, de Jong PA, Aerts J, Oudkerk M, de Koning HJ, Ten Haaf K, NELSON trial consortium
doi: 10.1038/s41467-025-63471-6
Lung Cancer
Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer
Sci Rep
Chen HL, Chueh CH, Huang WM, Chan SH, Cheng HH, Chiang SC, Wu CE, Wen YW, Tsai YW
doi: 10.1038/s41598-025-22966-4
RECOMMENDED
Lung Cancer
Quality Implementation of Lung Cancer Screening System (QUILS™ 1.0): A system to support high-quality delivery of lung cancer screening in diverse settings
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
Chest
Studts JL, Knight JR, Yates AR, Alexander JL, Damron KJ, Barry AM, Studts CR, Brooks MT, Mullett TW
doi: 10.1016/j.chest.2025.10.050
RECOMMENDED
Lung Cancer
The Effect of Exercise on Quality of Life in Patients With Advanced Lung Cancer: A Secondary Analysis of a Randomized Controlled Trial
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
Clin Lung Cancer
Bloch Z, Jensen S, Sørensen V, Langer SW, Quist M
doi: 10.1016/j.cllc.2025.07.005
Lung Cancer
Cost-effectiveness of adjuvant alectinib in the treatment of patients with resected stage IB-IIIA ALK-positive non-small lung cancer in France, based on the ALINA study
Lung Cancer
Supiot R, Gherardi A, du Manoir de Juaye L, Doghri O, Sivignon M, Duruisseaux M, Chouaid C
doi: 10.1016/j.lungcan.2025.108885
COMMENTED
Lung Cancer
Effectiveness of NELSON versus PLCOm2012 lung cancer screening eligibility criteria in Germany (HANSE): a prospective cohort study
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Lancet Oncol
Vogel-Claussen J, Bollmann BA, May K, Stiebeler S, Dettmer S, Faron A, Kuhlmann A, Schmid-Bindert G, Kaaks R, Barkhausen J, Bohnet S, Reck M, HANSE investigators
doi: 10.1016/S1470-2045(25)00490-5
Lung Cancer
The Counseling and Shared Decision-Making Visit for Lung Cancer Screening: A Thematic Analysis of Public Comments to the Centers for Medicare & Medicaid Services during the 2021-2022 National Coverage Analysis Process
Chest
Volk RJ, Maki KG, Rogova A, Tu A, Nguyen CVT, Ma H, Hoffman RM
doi: 10.1016/j.chest.2025.12.016
Lung Cancer
Real-world comparative effectiveness of sotorasib versus docetaxel monotherapy in second line and beyond for advanced or metastatic non-small cell lung cancer: A national database analysis from England
Lung Cancer
Karim N, Arnold K, Summers Y, Akram T, Trankov N, Vladimirova A, Chopra D, Mesa-Frias M, Waterhouse D, Stollenwerk B
doi: 10.1016/j.lungcan.2026.109469